Editor/NN
’/CD
s/NNS
Introduction/NN
to/TO
This/DT
Issue/NN
(/(
G/NN
&/CC
I/NN
16:4/CD
,/,
2018/CD
)/)
./.
====================
In/IN
this/DT
issue/NN
,/,
there/EX
are/VBP
24/CD
articles/NNS
:/:
five/CD
Review/NN
Articles/NNS
,/,
13/CD
Original/JJ
Articles/NNS
,/,
one/CD
Clinical/JJ
Genomics/NNS
,/,
four/CD
Application/NN
Notes/NNS
,/,
and/CC
one/CD
Opinion/NN
article/NN
./.
====================
The/DT
first/JJ
review/NN
is/VBZ
about/RB
single-cell/JJ
sequencing/NN
in/IN
cancer/NN
./.
====================
Single-cell/JJ
sequencing/NN
technologies/NNS
already/RB
have/VBP
led/VBN
to/TO
many/JJ
discoveries/NNS
in/IN
the/DT
field/NN
of/IN
cancer/NN
immunology/NN
and/CC
proven/VBN
it/PRP
can/MD
provide/VB
further/JJ
insight/NN
into/IN
understanding/NN
of/IN
intratumor/JJ
heterogeneity/NN
,/,
immunoediting/VBG
,/,
and/CC
immunogenicity/NN
that/DT
are/VBP
difficult/JJ
to/TO
resolve/VB
from/IN
bulk/NN
sequencing/NN
./.
====================
The/DT
comprehensive/JJ
review/NN
by/IN
Sierant/JJ
and/CC
Choi/NNP
(/(
Yale/JJ
University/JJ
,/,
New/JJ
Haven/JJ
,/,
CT/NN
,/,
USA/NNP
)/)
presents/VBZ
reviews/VBZ
on/IN
the/DT
perspectives/NNS
of/IN
single-cell/JJ
genomic/JJ
analysis/NN
in/IN
cancer/NN
immunology/NN
,/,
the/DT
potential/JJ
pitfalls/NNS
of/IN
different/JJ
single-cell/JJ
analysis/NN
technology/NN
,/,
and/CC
the/DT
therapeutic/JJ
opportunity/NN
for/IN
cancer/NN
treatment/NN
as/IN
the/DT
hallmarks/NNS
of/IN
precision/NN
medicine/JJ
in/IN
the/DT
future/JJ
./.
====================
The/DT
second/JJ
review/NN
article/NN
of/IN
Do/NN
and/CC
Kim/NN
(/(
Korea/NN
National/JJ
University/NN
of/IN
Education/NN
)/)
discussed/VBN
the/DT
roles/NNS
long/JJ
non-coding/JJ
RNAs/NNS
(/(
lncRNAs/NNS
)/)
in/IN
biological/JJ
processes/NNS
and/CC
describe/VBP
the/DT
lncRNA-mediated/JJ
signaling/NN
pathways/NNS
involved/VBN
in/IN
cancers/NNS
,/,
with/IN
a/DT
focus/JJ
on/IN
oncogenic/JJ
lncRNAs/NNS
./.
====================
Oncogenic/JJ
lncRNAs/NNS
have/VBP
the/DT
potential/JJ
to/TO
become/VB
promising/VBG
biomarkers/NNS
and/CC
might/MD
be/VB
potent/JJ
prognostic/JJ
targets/NNS
in/IN
cancer/NN
therapy/NN
./.
====================
This/DT
review/NN
summarizes/VBZ
studies/NNS
on/IN
the/DT
regulatory/JJ
and/CC
functional/JJ
roles/NNS
of/IN
oncogenic/JJ
lncRNAs/NNS
in/IN
the/DT
development/NN
and/CC
progression/NN
of/IN
various/JJ
types/NNS
of/IN
cancer/NN
./.
====================
The/DT
third/JJ
review/NN
by/IN
Seunghee/JJ
Cha/NN
(/(
University/NN
of/IN
Florida/NN
,/,
Gainesville/NN
,/,
FL/NN
,/,
USA/NNP
)/)
and/CC
colleagues/NNS
provide/VBP
an/DT
excellent/JJ
review/NN
on/IN
microRNAs/NNS
(/(
miRNAs/NNS
)/)
in/IN
Autoimmune/JJ
Sjögren/NN
’/CD
s/NNS
Syndrome/NN
(/(
SjS/NN
)/)
./.
====================
This/DT
review/NN
compiles/NNS
and/CC
highlights/VBZ
differentially-expressed/VBD
miRNAs/NNS
in/IN
various/JJ
samples/NNS
collected/JJ
from/IN
SjS/NN
patients/NNS
and/CC
their/PRP$
potential/JJ
implications/NNS
in/IN
the/DT
pathogenesis/NN
of/IN
SjS/NN
./.
====================
This/DT
review/NN
suggests/VBZ
potential/JJ
clinical/JJ
implications/NNS
of/IN
miRNAs/NNS
to/TO
select/VB
disease-specific/JJ
diagnostic/JJ
and/CC
prognostic/JJ
biomarkers/NNS
by/IN
utilizing/VBG
different/JJ
types/NNS
of/IN
tissues/NNS
or/CC
biological/JJ
specimens/NNS
of/IN
SjS/NN
patients/NNS
./.
====================
The/DT
fourth/JJ
review/NN
is/VBZ
about/RB
genetic/JJ
hearing/NN
loss/NN
and/CC
gene/NN
therapy/NN
./.
====================
Carpena/NN
and/CC
Lee/NNP
(/(
Dankook/NN
University/NN
,/,
Cheonan/NNP
,/,
Korea/NN
)/)
consolidated/VBD
the/DT
genes/NNS
that/WDT
are/VBP
currently/RB
identified/VBN
to/TO
be/VB
associated/VBN
with/IN
hearing/JJ
loss/NN
./.
====================
They/PRP
provided/VBD
reviews/VBZ
on/IN
the/DT
recent/JJ
advances/NNS
in/IN
elucidating/VBG
the/DT
genomics/NNS
of/IN
genetic/JJ
hearing/NN
loss/NN
and/CC
technologies/NNS
aimed/VBD
at/IN
developing/VBG
a/DT
gene/NN
therapy/NN
that/IN
may/MD
become/VB
a/DT
treatment/NN
option/NN
for/IN
in/IN
the/DT
near/JJ
future/JJ
./.
====================
The/DT
final/JJ
review/NN
by/IN
Jeon/NN
and/CC
Galvao/FW
(/(
Long/JJ
Island/CC
University/NN
,/,
Brookville/JJ
,/,
NY/NN
,/,
USA/NNP
)/)
focused/VBD
on/IN
some/DT
recent/JJ
studies/NNS
based/VBN
on/IN
high-throughput/JJ
sequencing/NN
claiming/VBG
that/DT
metritis/NN
is/VBZ
a/DT
microbiota-associated/JJ
disease/NN
./.
====================
They/PRP
provided/VBD
the/DT
reviews/VBZ
some/DT
recent/JJ
studies/NNS
that/IN
used/VBN
metagenomic/JJ
approaches/NNS
to/TO
explore/VB
uterine/JJ
bacterial/JJ
community/NN
involved/VBN
in/IN
metritis/NN
and/CC
discuss/VBP
uterine/JJ
bacteria/NNS
that/DT
are/VBP
known/VBN
and/CC
newly/RB
identified/VBN
in/IN
metagenomic/JJ
sequencing/NN
./.
====================
They/PRP
proposed/VBN
that/IN
metritis/NN
is/VBZ
associated/VBN
with/IN
uterine/JJ
microbiota/NNS
with/IN
high/JJ
abundance/NN
of/IN
Bacteroides/NNS
,/,
Porphyromonas/NN
,/,
and/CC
Fusobacterium/NN
./.
====================
This/DT
issue/NN
contains/VBZ
13/CD
Original/JJ
Articles/NNS
articles/NNS
./.
====================
First/RB
,/,
there/EX
are/VBP
three/CD
articles/NNS
on/IN
metagenome/NN
./.
====================
With/IN
the/DT
development/NN
of/IN
genome/NN
sequence/NN
analysis/NN
technology/NN
,/,
there/EX
is/VBZ
an/DT
increasing/VBG
demand/CC
for/IN
virus/NN
taxonomy/NN
to/TO
be/VB
extended/VBN
from/IN
in/FW
vivo/FW
and/CC
in/IN
vitro/FW
to/TO
in/IN
silico/NN
./.
====================
Kang/VBG
and/CC
Kim/NN
(/(
Chungbuk/NNP
National/JJ
University/NN
,/,
Cheongju/NNP
,/,
Korea/NN
)/)
verified/VBN
the/DT
consistency/NN
of/IN
the/DT
current/JJ
International/NNP
Classification/NN
of/IN
Viruses/NNS
(/(
ICTV/NN
)/)
taxonomy/NN
using/VBG
an/DT
in/FW
silico/NN
approach/NN
,/,
aiming/VBG
to/TO
identify/VB
the/DT
specific/JJ
sequence/NN
for/IN
each/DT
virus/NN
./.
====================
They/PRP
applied/VBD
this/DT
approach/NN
to/TO
norovirus/NN
in/IN
Caliciviridae/FW
,/,
which/WDT
causes/VBZ
90/CD
%/NN
of/IN
gastroenteritis/NN
cases/NNS
worldwide/NN
./.
====================
In/IN
their/PRP$
second/JJ
article/NN
,/,
Kang/NNP
and/CC
Kim/NN
constructed/VBN
a/DT
web-based/JJ
system/NN
and/CC
extension/NN
of/IN
an/DT
associated/VBN
database/NN
,/,
based/VBN
on/IN
ICTV/NN
taxonomy/NN
./.
====================
Their/PRP$
virus/NN
taxonomy/NN
web/NN
system/NN
was/VBD
specifically/RB
designed/VBN
to/TO
extend/VB
the/DT
virus/NN
taxonomy/NN
up/IN
to/TO
strain/NN
and/CC
isolation/NN
,/,
which/WDT
was/VBD
then/RB
connected/VBD
with/IN
the/DT
NCBI/NN
database/NN
to/TO
facilitate/VB
searching/VBG
for/IN
specific/JJ
viral/JJ
genes/NNS
;/:
there/EX
are/VBP
also/RB
links/VBZ
to/TO
journals/NNS
provided/VBD
by/IN
the/DT
EMBL/NN
RESTful/JJ
API/NN
that/DT
improve/VBP
accessibility/NN
for/IN
academic/JJ
groups/NNS
./.
====================
Thus/RB
,/,
the/DT
web-based/JJ
virus/NN
taxonomy/NN
could/MD
be/VB
augmented/VBN
the/DT
quality/NN
by/IN
adding/VBG
virus/NN
classification/NN
,/,
which/WDT
is/VBZ
derived/VBN
by/IN
virus/NN
metagenomics/NNS
analysis/NN
./.
====================
Taxonomy/NN
identification/NN
is/VBZ
fundamental/JJ
to/TO
in/IN
metagenomics/NNS
./.
====================
Park/NN
and/CC
Won/NN
(/(
Institute/JJ
of/IN
Health/NN
and/CC
Environment/JJ
,/,
Seoul/JJ
National/JJ
University/NN
,/,
Seoul/JJ
,/,
Korea/NN
)/)
evaluated/VBD
the/DT
accuracy/NN
of/IN
three/CD
widely/RB
used/VBN
16S/NN
databases/NNS
,/,
Greengenes/NNS
,/,
Silva/NN
,/,
and/CC
EzBioCloud/JJ
,/,
and/CC
suggested/VBD
basic/JJ
guidelines/NNS
for/IN
selecting/VBG
reference/VBP
databases/NNS
./.
====================
Using/VBG
public/JJ
mock/NN
community/NN
data/NNS
,/,
they/PRP
showed/VBD
that/IN
EzBioCloud/JJ
performs/NNS
well/RB
compared/VBN
to/TO
other/JJ
existing/VBG
databases/NNS
./.
====================
In/IN
this/DT
issue/NN
,/,
there/EX
is/VBZ
one/CD
on/IN
transcriptomics/NNS
./.
====================
Niloofar/RB
Avazpour/NN
(/(
Shahid/NN
Chamran/NNP
University/JJ
of/IN
Ahvaz/NN
,/,
Ahvaz/NNP
,/,
Iran/NNP
)/)
and/CC
colleagues/NNS
showed/VBD
that/IN
HOTAIR/NN
,/,
one/CD
of/IN
the/DT
most/JJS
cited/VBN
lncRNAs/NNS
with/IN
a/DT
critical/JJ
role/NN
in/IN
initiation/NN
and/CC
progression/NN
of/IN
the/DT
gene/NN
expression/NN
regulation/NN
,/,
can/MD
be/VB
a/DT
potential/JJ
biomarkers/NNS
for/IN
coronary/JJ
artery/NN
disease/NN
(/(
CAD/NN
)/)
./.
====================
They/PRP
compared/VBN
the/DT
expression/NN
of/IN
HOTAIR/NN
lncRNA/NN
in/IN
the/DT
blood/NN
samples/NNS
of/IN
patients/NNS
with/IN
CAD/NN
and/CC
control/NN
samples/NNS
./.
====================
The/DT
expression/NN
level/NN
was/VBD
examined/VBN
by/IN
semi-quantitative/JJ
reverse/JJ
transcriptase/NN
polymerase/NN
chain/NN
reaction/NN
technique/NN
./.
====================
They/PRP
showed/VBD
that/IN
expression/NN
of/IN
HOTAIR/NN
is/VBZ
up-regulated/VBN
in/IN
blood/NN
samples/NNS
of/IN
patients/NNS
with/IN
CAD/NN
./.
====================
Md/JJ
./.
====================
Amran/DT
Gazi/NNP
(/(
International/NNP
Centre/NNP
for/IN
Diarrhoeal/JJ
Disease/NN
Research/NN
,/,
Dhaka/NNP
,/,
Bangladesh/JJ
)/)
and/CC
his/NN
colleagues/NNS
extensively/RB
analyzed/VBD
the/DT
genome/NN
of/IN
Shigella/NN
flexneri/NN
and/CC
found/VBD
4,362/CD
proteins/NNS
among/IN
which/WDT
the/DT
functions/NNS
of/IN
674/CD
proteins/NNS
,/,
termed/VBN
as/IN
hypothetical/JJ
proteins/NNS
(/(
HPs/NNS
)/)
had/VBD
not/RB
been/VBN
previously/RB
elucidated/VBN
./.
====================
These/DT
HPs/NNS
were/VBD
found/VBN
to/TO
belong/VB
to/TO
various/JJ
classes/NNS
of/IN
proteins/NNS
such/JJ
as/IN
enzymes/NNS
,/,
binding/VBG
proteins/NNS
,/,
signal/NN
transducers/NNS
,/,
lipoprotein/NN
,/,
transporters/VBZ
,/,
virulence/NN
,/,
and/CC
other/JJ
proteins/NNS
./.
====================
Their/PRP$
comprehensive/JJ
analysis/NN
will/MD
help/VB
to/TO
gain/VB
greater/JJR
understanding/NN
for/IN
the/DT
development/NN
of/IN
many/JJ
novel/JJ
potential/JJ
therapeutic/JJ
interventions/NNS
to/TO
defeat/VB
Shigella/NN
infection/NN
./.
====================
In/IN
this/DT
issue/NN
,/,
there/EX
are/VBP
also/RB
several/JJ
articles/NNS
on/IN
Informatics/NNS
./.
====================
Hyun-Seok/RB
Park/NN
(/(
Ewha/NN
Womans/NNS
University/NN
,/,
Korea/NN
)/)
investigated/VBD
the/DT
effect/NN
of/IN
the/DT
primary/JJ
DNA/NN
sequence/NN
on/IN
the/DT
epigenomic/JJ
landscape/NN
across/IN
a/DT
200-base/JJ
pair/NN
of/IN
genomic/JJ
units/NNS
by/IN
integrating/VBG
127/CD
publicly/RB
available/JJ
ChromHMM/NN
BED/NN
files/NNS
from/IN
the/DT
Roadmap/NN
Genomics/NNS
project/VB
./.
====================
He/RB
analyzed/VBD
nucleotide/NN
frequency/NN
profiles/NNS
of/IN
127/NN
chromatin/NN
annotations/NNS
stratified/JJ
by/IN
chromatin/NN
variability/NN
and/CC
built/JJ
integrative/JJ
hidden/JJ
Markov/NNP
models/NNS
to/TO
detect/VB
Markov/NNP
properties/NNS
of/IN
chromatin/NN
regions/NNS
./.
====================
Jonghwan/DT
Yoon/NN
(/(
The/DT
Catholic/JJ
University/JJ
of/IN
Korea/NN
,/,
Seoul/JJ
,/,
Korea/NN
)/)
and/CC
his/NN
colleagues/NNS
studied/VBN
the/DT
tRNA/NN
adaptation/NN
index/NN
which/WDT
is/VBZ
a/DT
measure/JJ
of/IN
translational/JJ
efficiency/NN
for/IN
a/DT
gene/NN
and/CC
is/VBZ
calculated/VBN
based/VBN
on/IN
the/DT
abundance/NN
of/IN
intracellular/JJ
tRNA/NN
and/CC
the/DT
binding/VBG
strength/NN
between/IN
a/DT
codon/NN
and/CC
a/DT
tRNA/NN
./.
====================
The/DT
index/NN
has/VBZ
been/VBN
widely/RB
used/VBN
in/IN
various/JJ
fields/NNS
of/IN
molecular/JJ
evolution/NN
,/,
genetics/NNS
,/,
and/CC
pharmacology/NN
./.
====================
For/IN
an/DT
improved/JJ
version/NN
of/IN
the/DT
index/NN
,/,
named/VBN
specific/JJ
tRNA/NN
adaptation/NN
index/NN
(/(
stAI/NN
)/)
,/,
they/PRP
calculated/VBD
stAI/NN
values/NNS
for/IN
whole/JJ
coding/VBG
sequences/NNS
in/IN
148/CD
species/NNS
./.
====================
In/IN
addition/NN
,/,
they/PRP
constructed/VBD
a/DT
novel/JJ
web/NN
database/NN
,/,
STADIUM/NN
(/(
Species-specific/JJ
tRNA/NN
adaptive/JJ
index/NN
compendium/NN
)/)
to/TO
enable/VB
easy/RB
access/VBP
to/TO
improved/JJ
version/NN
of/IN
this/DT
index/NN
./.
====================
Young-Joon/RB
Kim/NN
’/CD
s/NNS
group/NN
(/(
Yonsei/NNS
University/NN
,/,
Seoul/JJ
,/,
Korea/NN
)/)
built/CC
a/DT
hybrid/NN
capture-based/VBD
targeted/VBN
sequencing/NN
analysis/NN
pipeline/NN
for/IN
global/JJ
application/NN
to/TO
many/JJ
studies/NNS
of/IN
targeted/VBN
sequencing/NN
by/IN
using/VBG
genomic/JJ
DNA/NN
extracted/VBN
from/IN
tumor/NN
tissues/NNS
of/IN
colorectal/JJ
cancer/NN
patients/NNS
./.
====================
This/DT
pipeline/NN
was/VBD
specialized/VBN
for/IN
unique/JJ
molecular/JJ
index/NN
data/NNS
./.
====================
Through/IN
this/DT
pipeline/NN
,/,
they/PRP
were/VBD
able/JJ
to/TO
estimate/VB
the/DT
even/RB
on-target/JJ
rates/NNS
and/CC
filtered/JJ
consensus/NN
reads/VBZ
for/IN
more/RBR
accurate/JJ
variant/JJ
calling/JJ
./.
====================
These/DT
results/NNS
suggest/VBP
the/DT
potential/JJ
of/IN
our/PRP$
analysis/NN
pipeline/NN
in/IN
the/DT
precise/JJ
examination/NN
of/IN
quality/NN
and/CC
efficiency/NN
of/IN
conducted/JJ
experiments/NNS
./.
====================
In/IN
response/NN
to/TO
the/DT
urgent/JJ
need/VBD
for/IN
effective/JJ
and/CC
cost-efficient/JJ
data/NNS
,/,
DNA/NN
synthesis/NN
and/CC
sequencing/NN
has/VBZ
been/VBN
used/VBN
as/IN
a/DT
new/JJ
tool/NN
for/IN
storing/VBG
digital/JJ
information/NN
./.
====================
Most/JJS
studies/NNS
have/VBP
focused/VBN
on/IN
making/VBG
use/NN
of/IN
100–150/CD
bp/NN
of/IN
short/JJ
read/VBN
sizse/NN
in/IN
both/CC
synthesis/NN
and/CC
sequencing/NN
./.
====================
TaeJin/NN
Ahn/NN
’/CD
s/NNS
group/NN
(/(
Handong/JJ
University/NN
,/,
Pohang/NNP
,/,
Korea/NN
)/)
suggested/VBD
novel/JJ
data/NNS
encoding/VBG
//:
decoding/VBG
scheme/NN
which/WDT
makes/VBZ
use/NN
of/IN
long/JJ
read/JJ
DNA/NN
(/(
∼1,000/CD
bp/NN
)/)
./.
====================
Longer/JJ
DNA/NN
read/NN
can/MD
store/VB
larger/JJR
amount/NN
of/IN
digital/JJ
information/NN
within/IN
a/DT
single/JJ
molecule/NN
./.
====================
Thus/RB
,/,
their/PRP$
approach/NN
is/VBZ
more/RBR
scalable/JJ
than/IN
short/JJ
DNA/NN
methods/NNS
and/CC
there/EX
is/VBZ
no/DT
need/RB
to/TO
wait/VB
for/IN
denovo/FW
synthesis/NN
of/IN
DNA/NN
./.
====================
In/IN
this/DT
issue/NN
,/,
there/EX
are/VBP
several/JJ
articles/NNS
on/IN
data/NNS
mining/VBG
and/CC
statistical/JJ
application/NN
to/TO
omics/NNS
data/NNS
./.
====================
The/DT
first/JJ
article/NN
is/VBZ
about/RB
metabolic/JJ
syndrome/NN
(/(
MS/NN
)/)
in/IN
the/DT
nonobese/JJ
population/NN
./.
====================
While/IN
the/DT
prevalence/NN
of/IN
MS/NN
in/IN
the/DT
nonobese/JJ
population/NN
is/VBZ
not/RB
low/JJ
,/,
the/DT
identification/NN
and/CC
risk/NN
mitigation/NN
of/IN
MS/NN
are/VBP
not/RB
easy/RB
./.
====================
Seung/JJ
Ho/NN
Cho/NN
’/CD
s/NNS
group/NN
(/(
Seoul/JJ
National/JJ
University/NN
Hospital/JJ
)/)
developed/VBD
an/DT
MS/NN
prediction/NN
model/NN
using/VBG
genetic/JJ
and/CC
clinical/JJ
factors/NNS
of/IN
nonobese/JJ
Koreans/NNS
with/IN
five/CD
machine/JJ
learning/VBG
algorithms/NNS
,/,
including/VBG
naïve/JJ
Bayes/NNS
classification/NN
(/(
NB/NN
)/)
./.
====================
The/DT
analysis/NN
was/VBD
performed/VBN
in/IN
two/CD
stages/NNS
(/(
training/VBG
and/CC
test/VB
sets/NNS
)/)
with/IN
evaluation/NN
measures/NNS
such/JJ
as/IN
sensitivity/NN
,/,
specificity/NN
,/,
area/NN
under/IN
the/DT
receiver/NN
operating/VBG
characteristic/JJ
curve/JJ
./.
====================
While/IN
the/DT
performance/NN
of/IN
NB/NN
was/VBD
best/JJS
,/,
its/PRP$
prediction/NN
performance/NN
was/VBD
not/RB
as/IN
good/JJ
as/IN
expected/VBN
./.
====================
The/DT
second/JJ
article/NN
is/VBZ
about/RB
building/VBG
prognostic/JJ
prediction/NN
model/NN
of/IN
ovarian/JJ
cancer/NN
./.
====================
Seokho/DT
Jeong/JJ
(/(
Seoul/JJ
National/JJ
University/JJ
,/,
Seoul/JJ
,/,
Korea/NN
)/)
and/CC
his/DT
colleagues/NNS
presented/VBN
an/DT
efficient/JJ
strategy/NN
to/TO
build/JJ
a/DT
prognostic/JJ
prediction/NN
model/NN
of/IN
ovarian/JJ
cancer/NN
by/IN
integrating/VBG
the/DT
high/JJ
dimensional/JJ
RNA/NN
sequencing/NN
data/NNS
with/IN
their/PRP$
clinical/JJ
data/NNS
through/IN
the/DT
following/VBG
steps/NNS
:/:
(/(
1/LS
)/)
gene/NN
filtration/NN
,/,
(/(
2/CD
)/)
pre-screening/VBG
,/,
(/(
3/LS
)/)
gene/NN
marker/NN
selection/NN
,/,
and/CC
(/(
4/CD
)/)
integration/NN
of/IN
selected/VBN
gene/NN
markers/NNS
and/CC
prediction/NN
model/NN
building/VBG
./.
====================
This/DT
strategy/NN
is/VBZ
so/RB
general/JJ
that/DT
it/PRP
can/MD
be/VB
applied/VBN
to/TO
other/JJ
types/NNS
of/IN
cancer/NN
besides/VBZ
ovarian/JJ
cancer/NN
./.
====================
Finally/RB
,/,
the/DT
third/JJ
article/NN
is/VBZ
about/RB
multi-block/NN
analysis/NN
of/IN
genomic/JJ
data/NNS
./.
====================
In/IN
general/JJ
,/,
multi-block/JJ
data/NNS
is/VBZ
used/VBN
for/IN
enhancing/VBG
analysis/NN
of/IN
different/JJ
block/VBP
’/CD
s/NNS
relationship/NN
./.
====================
Mira/NNS
Park/NN
’/CD
s/NNS
group/NN
(/(
Eulji/NN
University/NN
,/,
Daejeon/NN
,/,
Korea/NN
)/)
performed/VBN
multi-block/JJ
analysis/NN
of/IN
genomic/JJ
data/NNS
./.
====================
Using/VBG
generalized/VBN
canonical/JJ
correlation/NN
analysis/NN
,/,
they/PRP
could/MD
identify/VB
relationships/NNS
between/IN
SNP/NN
block/VBP
,/,
phenotype/NN
block/VBP
,/,
and/CC
disease/NN
block/VBP
data/NNS
from/IN
Korean/JJ
Association/NN
Resource/NN
(/(
KARE/NN
)/)
project/VBP
./.
====================
There/EX
is/VBZ
one/CD
interesting/JJ
article/NN
on/IN
a/DT
Korean/JJ
medicinal/JJ
herb/NN
./.
====================
Neha/NN
Samir/NN
Roy/NNP
(/(
Kangwon/NN
National/JJ
University/NN
,/,
Chuncheon/JJ
,/,
Korea/NN
)/)
and/CC
colleagues/NNS
reported/VBD
the/DT
first/JJ
de/FW
novo/FW
assembly/NN
of/IN
the/DT
transcriptome/JJ
of/IN
Cirsium/NN
japonicum/NN
var/JJ
./.
====================
spinossimum/NN
obtained/VBN
from/IN
the/DT
Korean/JJ
Peninsula/NN
./.
====================
They/PRP
identified/VBD
the/DT
expression/NN
of/IN
genes/NNS
related/JJ
to/TO
the/DT
synthesis/NN
of/IN
silymarin/NN
in/IN
C./FW
japonicum/NN
in/IN
three/CD
different/JJ
tissues/NNS
,/,
flowers/NNS
,/,
leaves/VBZ
and/CC
roots/NNS
,/,
through/IN
RNA/NN
sequencing/NN
./.
====================
Their/PRP$
study/NN
provided/VBD
resources/NNS
for/IN
comparative/JJ
transcriptomics/NNS
,/,
especially/RB
in/IN
the/DT
field/NN
of/IN
the/DT
biochemical/JJ
and/CC
molecular/JJ
biosynthesis/NN
pathways/NNS
of/IN
silymarin/NN
./.
====================
In/IN
Clinical/JJ
Genomics/NNS
section/NN
,/,
there/EX
is/VBZ
one/CD
article/NN
./.
====================
Kyong-Ah/NN
Yoon/NN
(/(
Konkuk/NN
University/NN
,/,
Seoul/JJ
,/,
Korea/NN
)/)
and/CC
her/RB
colleagues/NNS
reported/VBD
the/DT
genetic/JJ
characteristics/NNS
of/IN
biliary/JJ
tract/NN
cancer/NN
(/(
BTC/NN
)/)
./.
====================
They/PRP
analyzed/VBD
whole/JJ
exome/NN
sequencing/NN
data/NNS
and/CC
identified/VBD
somatic/JJ
mutations/NNS
from/IN
the/DT
seven/CD
BTC/NN
patients/NNS
with/IN
cholangiocarcinoma/NN
who/WP
were/VBD
underwent/JJ
surgical/JJ
resection/NN
./.
====================
They/PRP
discovered/VBD
inactivating/VBG
mutations/NNS
of/IN
tumor/NN
suppressor/NN
genes/NNS
including/VBG
APC/NN
,/,
TP53/NN
,/,
and/CC
ARID1A/NN
genes/NNS
in/IN
three/CD
patients/NNS
./.
====================
Activating/VBG
mutations/NNS
of/IN
KRAS/JJ
and/CC
NRAS/NN
were/VBD
also/RB
identified/VBD
./.
====================
In/IN
the/DT
Application/NN
Note/NN
section/NN
,/,
four/CD
programs/NNS
are/VBP
introduced/VBN
./.
====================
For/IN
the/DT
integrative/JJ
analysis/NN
of/IN
the/DT
RNA/NN
sequencing/NN
(/(
RNA-Seq/NNP
)/)
data/NNS
,/,
Sang/NNP
Cheol/NNP
Kim/NN
(/(
National/JJ
Institute/RB
of/IN
Health/NN
,/,
Cheongju/NNP
,/,
Korea/NN
)/)
and/CC
his/DT
colleagues/NNS
developed/VBD
a/DT
web-based/JJ
application/NN
using/VBG
Shiny/JJ
,/,
COEX-seq/NNP
(/(
Convert/NNP
a/DT
Variety/NN
of/IN
Measurements/NNS
of/IN
Gene/NN
Expression/NN
in/IN
RNA-Seq/JJ
)/)
that/IN
easily/RB
converts/VBZ
data/NNS
in/IN
a/DT
variety/NN
of/IN
measurement/JJ
formats/NNS
of/IN
gene/NN
expression/NN
used/VBN
in/IN
most/JJS
bioinformatics/NNS
tools/NNS
for/IN
RNA-Seq/JJ
./.
====================
It/PRP
provides/VBZ
a/DT
workflow/NN
that/DT
includes/VBZ
loading/VBG
data/NNS
set/VBP
,/,
selecting/VBG
measurement/NN
formats/NNS
of/IN
gene/NN
expression/NN
,/,
and/CC
identifying/VBG
gene/NN
names/NNS
./.
====================
COEX-seq/NN
is/VBZ
freely/RB
available/JJ
for/IN
academic/JJ
purposes/NNS
and/CC
can/MD
be/VB
run/JJ
on/IN
Windows/VBZ
,/,
Mac/NN
OS/NN
,/,
and/CC
Linux/JJ
operating/VBG
systems/NNS
./.
====================
Source/NN
code/VBP
,/,
sample/NN
data/NNS
sets/NNS
,/,
and/CC
supplementary/JJ
documentation/NN
are/VBP
available/JJ
as/IN
well/RB
./.
====================
It/PRP
is/VBZ
well/RB
known/VBN
that/IN
gene-gene/NN
interaction/NN
is/VBZ
a/DT
key/JJ
factor/NN
to/TO
explain/VB
the/DT
missing/JJ
heritability/NN
in/IN
genome-wide/NN
association/NN
studies/NNS
(/(
GWAS/NN
)/)
./.
====================
Many/JJ
methods/NNS
have/VBP
been/VBN
proposed/VBN
to/TO
identify/VB
gene-gene/NN
interactions/NNS
./.
====================
Multi-factor/JJ
dimensionality/NN
reduction/NN
(/(
MDR/NN
)/)
is/VBZ
a/DT
well-known/JJ
method/NN
for/IN
gene-gene/NN
interaction/NN
detection/NN
by/IN
reduction/NN
from/IN
genotypes/NNS
of/IN
SNP/NN
combination/NN
to/TO
a/DT
binary/JJ
variable/JJ
with/IN
a/DT
value/NN
of/IN
high/JJ
risk/NN
or/CC
low/JJ
risk/NN
./.
====================
Sangseob/NN
Leem/NNP
(/(
Seoul/JJ
National/JJ
University/NN
,/,
Seoul/JJ
,/,
Korea/NN
)/)
and/CC
his/NN
colleague/NN
proposed/VBN
empirical/JJ
fuzzy/RB
MDR/NN
(/(
EFMDR/NN
)/)
by/IN
combining/VBG
maximum/JJ
likelihood/JJ
estimation/NN
and/CC
fuzzy/RB
set/NN
theory/JJ
into/IN
MDR/NN
and/CC
implemented/VBD
EFMDR/NN
using/VBG
RCPP/NN
(/(
c/NN
+/CC
+/CC
package/NN
)/)
for/IN
faster/JJR
executions/NNS
./.
====================
Sungkyoung/NN
Choi/NNP
(/(
Yonsei/NNS
University/NN
College/NN
of/IN
Medicine/NN
,/,
Seoul/JJ
,/,
Korea/NN
)/)
also/RB
developed/VBD
the/DT
hierarchical/JJ
structural/JJ
component/NN
model/NN
for/IN
gene-gene/NN
interaction/NN
analysis/NN
for/IN
a/DT
continuous/JJ
phenotype/NN
./.
====================
The/DT
software/JJ
HisCoM-GGI/NN
is/VBZ
for/IN
performing/VBG
this/DT
gene-level/JJ
and/CC
SNP-level/JJ
interaction/NN
analysis/NN
./.
====================
HisCoM-GGI/NN
handles/NNS
various/JJ
type/NN
of/IN
genomic/JJ
data/NNS
,/,
and/CC
supports/VBZ
a/DT
data/NNS
management/VBP
and/CC
multithreading/JJ
to/TO
improve/VB
the/DT
efficiency/NN
of/IN
GWAS/NN
data/NNS
analysis/NN
./.
====================
HisCoM-GGI/NN
is/VBZ
expected/VBN
to/TO
provide/VB
advanced/JJ
accessibility/NN
to/TO
the/DT
researchers/NNS
on/IN
the/DT
genetic/JJ
interaction/NN
studies/NNS
and/CC
a/DT
more/RBR
effective/JJ
way/NN
to/TO
understand/VB
biological/JJ
mechanisms/NNS
of/IN
complex/NN
diseases/NNS
./.
====================
Sungyoung/NN
Lee/NNP
(/(
Seoul/JJ
National/JJ
University/NN
Hospital/JJ
,/,
Seoul/JJ
,/,
Korea/NN
)/)
and/CC
his/NN
colleagues/NNS
proposed/VBN
a/DT
novel/JJ
statistical/JJ
method/NN
that/DT
enables/VBZ
the/DT
pathway-based/JJ
association/NN
study/NN
of/IN
large-scale/JJ
genetic/JJ
dataset/NN
./.
====================
The/DT
software/JJ
PHARAOH/NN
is/VBZ
for/IN
performing/VBG
this/DT
pathway/NN
analysis/NN
./.
====================
PHARAOH/NN
program/NN
not/RB
only/RB
supports/VBZ
various/JJ
de/FW
facto/NN
standard/JJ
genetic/JJ
data/NNS
formats/VBZ
but/CC
also/RB
provides/VBZ
many/JJ
quality/NN
control/NN
measures/NNS
and/CC
filters/NNS
based/VBN
on/IN
those/DT
measures/NNS
./.
====================
PHARAOH/NN
can/MD
provide/VB
advanced/JJ
accessibility/NN
of/IN
the/DT
pathway-level/NN
analysis/NN
of/IN
large-scale/JJ
genetic/JJ
datasets/NNS
to/TO
researchers/NNS
./.
====================
Finally/RB
,/,
in/IN
the/DT
new/JJ
Opinion/NN
section/NN
,/,
Hyun-Seok/NN
Park/NN
(/(
Ewha/NN
Womans/NNS
University/NN
,/,
Seoul/JJ
,/,
Korea/NN
)/)
presented/VBN
his/DT
opinion/NN
on/IN
Strategy/NN
of/IN
Semi-Automatically/RB
Annotating/VBG
Full/JJ
Text/NN
Corpus/NN
of/IN
Genomics/NNS
&/CC
Informatics/NNS
(/(
GNI/NN
)/)
./.
====================
He/RB
listed/VBN
issues/NNS
associated/VBN
with/IN
upgrading/VBG
annotations/NNS
,/,
and/CC
gave/VBD
opinion/NN
on/IN
methodology/NN
to/TO
develop/VB
next/RB
version/NN
of/IN
GNI/NN
corpus/NN
based/VBN
on/IN
a/DT
semi-automatic/JJ
strategy/NN
for/IN
more/RBR
linguistically/RB
rich/JJ
corpus/NN
annotation/NN
./.
====================
